1	(	_	(	_	_	11	P	_	_
2	During	_	IN	_	_	11	TMP	_	_
3	its	_	PRP$	_	_	5	NMOD	_	_
4	centennial	_	JJ	_	_	5	NMOD	_	_
5	year	_	NN	_	_	2	PMOD	_	_
6	,	_	,	_	_	11	P	_	_
7	The	_	DT	_	_	10	NMOD	_	_
8	Wall	_	NNP	_	_	10	NAME	_	_
9	Street	_	NNP	_	_	10	NAME	_	_
10	Journal	_	NNP	_	_	11	SBJ	_	_
11	will	_	MD	_	_	0	ROOT	_	_
12	report	_	VB	_	_	11	VC	_	_
13	events	_	NNS	_	_	12	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	past	_	JJ	_	_	17	NMOD	_	_
17	century	_	NN	_	_	14	PMOD	_	_
18	that	_	DT	_	_	19	SBJ	_	_
19	stand	_	NN	_	_	13	NMOD	_	_
20	as	_	IN	_	_	19	ADV	_	_
21	milestones	_	NNS	_	_	20	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	American	_	JJ	_	_	25	NMOD	_	_
24	business	_	NN	_	_	25	NMOD	_	_
25	history	_	NN	_	_	22	PMOD	_	_
26	.	_	.	_	_	11	P	_	_
27	)	_	)	_	_	11	P	_	_

1	LUTHER	_	NNP	_	_	2	NAME	_	_
2	BURBANK	_	NNP	_	_	3	SBJ	_	_
3	CROSS-BRED	_	VBD	_	_	0	ROOT	_	_
4	PLANTS	_	NNS	_	_	3	OBJ	_	_
5	to	_	TO	_	_	3	PRP	_	_
6	produce	_	VB	_	_	5	IM	_	_
7	the	_	DT	_	_	10	NMOD	_	_
8	billion-dollar	_	JJ	_	_	10	NMOD	_	_
9	Idaho	_	NNP	_	_	10	NMOD	_	_
10	potato	_	NN	_	_	6	OBJ	_	_
11	.	_	.	_	_	3	P	_	_

1	Bioengineers	_	NNS	_	_	2	SBJ	_	_
2	set	_	VBD	_	_	0	ROOT	_	_
3	out	_	RP	_	_	2	PRT	_	_
4	to	_	TO	_	_	2	OPRD	_	_
5	duplicate	_	VB	_	_	4	IM	_	_
6	that	_	DT	_	_	7	NMOD	_	_
7	feat	_	NN	_	_	5	OBJ	_	_
8	--	_	:	_	_	9	P	_	_
9	scientifically	_	RB	_	_	5	PRN	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	commercially	_	RB	_	_	10	CONJ	_	_
12	--	_	:	_	_	9	P	_	_
13	with	_	IN	_	_	5	MNR	_	_
14	new	_	JJ	_	_	16	NMOD	_	_
15	life	_	NN	_	_	16	NMOD	_	_
16	forms	_	NNS	_	_	13	PMOD	_	_
17	.	_	.	_	_	2	P	_	_

1	In	_	IN	_	_	9	TMP	_	_
2	1953	_	CD	_	_	1	PMOD	_	_
3	,	_	,	_	_	9	P	_	_
4	James	_	NNP	_	_	5	NAME	_	_
5	Watson	_	NNP	_	_	9	SBJ	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	his	_	PRP$	_	_	8	NMOD	_	_
8	colleagues	_	NNS	_	_	6	CONJ	_	_
9	unlocked	_	VBD	_	_	0	ROOT	_	_
10	the	_	DT	_	_	12	NMOD	_	_
11	double	_	JJ	_	_	12	NMOD	_	_
12	helix	_	NN	_	_	9	OBJ	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	DNA	_	NN	_	_	13	PMOD	_	_
15	(	_	(	_	_	17	P	_	_
16	deoxyribonucleic	_	JJ	_	_	17	NMOD	_	_
17	acid	_	NN	_	_	14	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	,	_	,	_	_	14	P	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	genetic	_	JJ	_	_	22	NMOD	_	_
22	key	_	NN	_	_	14	APPO	_	_
23	to	_	TO	_	_	22	NMOD	_	_
24	heredity	_	NN	_	_	23	PMOD	_	_
25	.	_	.	_	_	9	P	_	_

1	Twenty	_	CD	_	_	2	NMOD	_	_
2	years	_	NNS	_	_	3	AMOD	_	_
3	later	_	RB	_	_	15	TMP	_	_
4	,	_	,	_	_	15	P	_	_
5	two	_	CD	_	_	7	NMOD	_	_
6	California	_	NNP	_	_	7	NMOD	_	_
7	academics	_	NNS	_	_	15	SBJ	_	_
8	,	_	,	_	_	7	P	_	_
9	Stanley	_	NNP	_	_	10	NAME	_	_
10	Cohen	_	NNP	_	_	7	APPO	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	Herbert	_	NNP	_	_	13	NAME	_	_
13	Boyer	_	NNP	_	_	11	CONJ	_	_
14	,	_	,	_	_	7	P	_	_
15	made	_	VBD	_	_	0	ROOT	_	_
16	``	_	``	_	_	19	P	_	_
17	recombinant	_	JJ	_	_	19	NMOD	_	_
18	''	_	''	_	_	19	P	_	_
19	DNA	_	NN	_	_	15	OBJ	_	_
20	,	_	,	_	_	15	P	_	_
21	transplanting	_	VBG	_	_	15	ADV	_	_
22	a	_	DT	_	_	23	NMOD	_	_
23	toad	_	NN	_	_	25	NMOD	_	_
24	's	_	POS	_	_	23	SUFFIX	_	_
25	gene	_	NN	_	_	21	OBJ	_	_
26	into	_	IN	_	_	21	ADV	_	_
27	bacteria	_	NNS	_	_	26	PMOD	_	_
28	,	_	,	_	_	27	P	_	_
29	which	_	WDT	_	_	31	SBJ	_	_
30	then	_	RB	_	_	31	TMP	_	_
31	reproduced	_	VBD	_	_	27	NMOD	_	_
32	toad	_	NN	_	_	33	NMOD	_	_
33	genes	_	NNS	_	_	31	OBJ	_	_
34	.	_	.	_	_	15	P	_	_

1	When	_	WRB	_	_	3	TMP	_	_
2	Boyer	_	NNP	_	_	3	SBJ	_	_
3	met	_	VBD	_	_	14	TMP	_	_
4	Robert	_	NNP	_	_	5	NAME	_	_
5	Swanson	_	NNP	_	_	3	OBJ	_	_
6	,	_	,	_	_	5	P	_	_
7	an	_	DT	_	_	9	NMOD	_	_
8	M.I.T.-trained	_	JJ	_	_	9	NMOD	_	_
9	chemist-turned-entrepreneur	_	NN	_	_	5	APPO	_	_
10	in	_	IN	_	_	3	TMP	_	_
11	1976	_	CD	_	_	10	PMOD	_	_
12	,	_	,	_	_	14	P	_	_
13	they	_	PRP	_	_	14	SBJ	_	_
14	saw	_	VBD	_	_	0	ROOT	_	_
15	dollar	_	NN	_	_	16	NMOD	_	_
16	signs	_	NNS	_	_	14	OBJ	_	_
17	.	_	.	_	_	14	P	_	_

1	With	_	IN	_	_	13	ADV	_	_
2	$	_	$	_	_	1	PMOD	_	_
3	500	_	CD	_	_	2	NMOD	_	_
4	apiece	_	RB	_	_	2	NMOD	_	_
5	and	_	CC	_	_	2	COORD	_	_
6	an	_	DT	_	_	7	NMOD	_	_
7	injection	_	NN	_	_	5	CONJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	outside	_	JJ	_	_	10	NMOD	_	_
10	capital	_	NN	_	_	8	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	they	_	PRP	_	_	13	SBJ	_	_
13	formed	_	VBD	_	_	0	ROOT	_	_
14	Genentech	_	NNP	_	_	13	OBJ	_	_
15	Inc	_	NNP	_	_	14	POSTHON	_	_
16	.	_	.	_	_	13	P	_	_

1	Commercial	_	JJ	_	_	2	NMOD	_	_
2	gene-splicing	_	NN	_	_	3	SBJ	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	born	_	VBN	_	_	3	VC	_	_
5	.	_	.	_	_	3	P	_	_

1	Genentech	_	NNP	_	_	4	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	first	_	JJ	_	_	4	NMOD	_	_
4	product	_	NN	_	_	12	SBJ	_	_
5	,	_	,	_	_	4	P	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	brain	_	NN	_	_	8	NMOD	_	_
8	protein	_	NN	_	_	4	APPO	_	_
9	called	_	VBD	_	_	8	APPO	_	_
10	somatostatin	_	NN	_	_	9	OPRD	_	_
11	,	_	,	_	_	4	P	_	_
12	proved	_	VBD	_	_	0	ROOT	_	_
13	its	_	PRP$	_	_	14	NMOD	_	_
14	technology	_	NN	_	_	12	OBJ	_	_
15	.	_	.	_	_	12	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	next	_	JJ	_	_	10	SBJ	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	be	_	VB	_	_	3	IM	_	_
5	cloned	_	VBN	_	_	4	VC	_	_
6	,	_	,	_	_	2	P	_	_
7	human	_	JJ	_	_	8	NMOD	_	_
8	insulin	_	NN	_	_	2	APPO	_	_
9	,	_	,	_	_	2	P	_	_
10	had	_	VBD	_	_	0	ROOT	_	_
11	market	_	NN	_	_	12	NMOD	_	_
12	potential	_	NN	_	_	10	OBJ	_	_
13	and	_	CC	_	_	10	COORD	_	_
14	Genentech	_	NNP	_	_	15	SBJ	_	_
15	licensed	_	VBD	_	_	13	CONJ	_	_
16	it	_	PRP	_	_	15	OBJ	_	_
17	to	_	TO	_	_	15	ADV	_	_
18	Eli	_	NNP	_	_	19	NAME	_	_
19	Lilly	_	NNP	_	_	17	PMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	which	_	WDT	_	_	22	SBJ	_	_
22	produced	_	VBD	_	_	19	NMOD	_	_
23	80	_	CD	_	_	24	NMOD	_	_
24	%	_	NN	_	_	22	OBJ	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	the	_	DT	_	_	27	NMOD	_	_
27	insulin	_	NN	_	_	25	PMOD	_	_
28	used	_	VBN	_	_	27	APPO	_	_
29	by	_	IN	_	_	28	LGS	_	_
30	1.5	_	CD	_	_	31	DEP	_	_
31	million	_	CD	_	_	33	NMOD	_	_
32	U.S.	_	NNP	_	_	33	NMOD	_	_
33	diabetics	_	NNS	_	_	29	PMOD	_	_
34	.	_	.	_	_	10	P	_	_

1	Their	_	PRP$	_	_	3	NMOD	_	_
2	laboratory	_	NN	_	_	3	NMOD	_	_
3	credentials	_	NNS	_	_	4	SBJ	_	_
4	established	_	VBN	_	_	9	DEP	_	_
5	,	_	,	_	_	9	P	_	_
6	Boyer	_	NNP	_	_	9	SBJ	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	Swanson	_	NNP	_	_	7	CONJ	_	_
9	headed	_	VBD	_	_	0	ROOT	_	_
10	for	_	IN	_	_	9	DIR	_	_
11	Wall	_	NNP	_	_	12	NAME	_	_
12	Street	_	NNP	_	_	10	PMOD	_	_
13	in	_	IN	_	_	9	TMP	_	_
14	1980	_	CD	_	_	13	PMOD	_	_
15	.	_	.	_	_	9	P	_	_

1	At	_	IN	_	_	6	TMP	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	time	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	Genentech	_	NN	_	_	6	SBJ	_	_
6	had	_	VBD	_	_	0	ROOT	_	_
7	only	_	RB	_	_	10	NMOD	_	_
8	one	_	CD	_	_	10	NMOD	_	_
9	profitable	_	JJ	_	_	10	NMOD	_	_
10	year	_	NN	_	_	6	OBJ	_	_
11	behind	_	IN	_	_	10	NMOD	_	_
12	it	_	PRP	_	_	11	PMOD	_	_
13	(	_	(	_	_	16	P	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	modest	_	JJ	_	_	16	NMOD	_	_
16	$	_	$	_	_	10	PRN	_	_
17	116,000	_	CD	_	_	16	NMOD	_	_
18	on	_	IN	_	_	16	NMOD	_	_
19	revenue	_	NN	_	_	18	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	$	_	$	_	_	20	PMOD	_	_
22	2.6	_	CD	_	_	21	DEP	_	_
23	million	_	CD	_	_	21	DEP	_	_
24	in	_	IN	_	_	19	TMP	_	_
25	1979	_	CD	_	_	24	PMOD	_	_
26	)	_	)	_	_	16	P	_	_
27	and	_	CC	_	_	10	COORD	_	_
28	no	_	DT	_	_	29	NMOD	_	_
29	product	_	NN	_	_	27	CONJ	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	its	_	PRP$	_	_	32	NMOD	_	_
32	own	_	JJ	_	_	30	PMOD	_	_
33	on	_	IN	_	_	29	LOC	_	_
34	the	_	DT	_	_	35	NMOD	_	_
35	market	_	NN	_	_	33	PMOD	_	_
36	.	_	.	_	_	6	P	_	_

1	Nonetheless	_	RB	_	_	12	ADV	_	_
2	,	_	,	_	_	12	P	_	_
3	the	_	DT	_	_	7	NMOD	_	_
4	$	_	$	_	_	7	NMOD	_	_
5	36	_	CD	_	_	4	DEP	_	_
6	million	_	CD	_	_	4	DEP	_	_
7	issue	_	NN	_	_	12	SBJ	_	_
8	they	_	PRP	_	_	9	SBJ	_	_
9	floated	_	VBD	_	_	7	NMOD	_	_
10	in	_	IN	_	_	9	TMP	_	_
11	1980	_	CD	_	_	10	PMOD	_	_
12	opened	_	VBD	_	_	0	ROOT	_	_
13	at	_	IN	_	_	12	ADV	_	_
14	$	_	$	_	_	13	PMOD	_	_
15	35	_	CD	_	_	14	NMOD	_	_
16	and	_	CC	_	_	12	COORD	_	_
17	leaped	_	VBD	_	_	16	CONJ	_	_
18	to	_	TO	_	_	17	DIR	_	_
19	$	_	$	_	_	18	PMOD	_	_
20	89	_	CD	_	_	19	NMOD	_	_
21	within	_	IN	_	_	17	TMP	_	_
22	20	_	CD	_	_	23	NMOD	_	_
23	minutes	_	NNS	_	_	21	PMOD	_	_
24	.	_	.	_	_	12	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	trip	_	NN	_	_	7	SBJ	_	_
3	from	_	IN	_	_	2	NMOD	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	test	_	NN	_	_	6	NMOD	_	_
6	tube	_	NN	_	_	3	PMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	not	_	RB	_	_	7	ADV	_	_
9	without	_	IN	_	_	7	PRD	_	_
10	snags	_	NNS	_	_	9	PMOD	_	_
11	.	_	.	_	_	7	P	_	_

1	Boyer	_	NNP	_	_	13	SBJ	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	Cohen	_	NNP	_	_	2	CONJ	_	_
4	,	_	,	_	_	5	P	_	_
5	for	_	IN	_	_	1	PRN	_	_
6	instance	_	NN	_	_	5	PMOD	_	_
7	,	_	,	_	_	5	P	_	_
8	both	_	DT	_	_	11	NMOD	_	_
9	still	_	RB	_	_	11	NMOD	_	_
10	university	_	NN	_	_	11	NMOD	_	_
11	researchers	_	NNS	_	_	1	APPO	_	_
12	,	_	,	_	_	1	P	_	_
13	had	_	VBD	_	_	0	ROOT	_	_
14	to	_	TO	_	_	13	OPRD	_	_
15	be	_	VB	_	_	14	IM	_	_
16	talked	_	VBN	_	_	15	VC	_	_
17	into	_	IN	_	_	16	ADV	_	_
18	applying	_	VBG	_	_	17	PMOD	_	_
19	for	_	IN	_	_	18	ADV	_	_
20	a	_	DT	_	_	21	NMOD	_	_
21	patent	_	NN	_	_	19	PMOD	_	_
22	on	_	IN	_	_	21	LOC	_	_
23	their	_	PRP$	_	_	25	NMOD	_	_
24	gene-splicing	_	NN	_	_	25	NMOD	_	_
25	technique	_	NN	_	_	22	PMOD	_	_
26	--	_	:	_	_	13	P	_	_
27	and	_	CC	_	_	13	COORD	_	_
28	then	_	RB	_	_	13	TMP	_	_
29	the	_	DT	_	_	31	NMOD	_	_
30	Patent	_	NNP	_	_	31	NAME	_	_
31	Office	_	NNP	_	_	32	SBJ	_	_
32	refused	_	VBD	_	_	27	CONJ	_	_
33	to	_	TO	_	_	32	OPRD	_	_
34	grant	_	VB	_	_	33	IM	_	_
35	it	_	PRP	_	_	34	OBJ	_	_
36	.	_	.	_	_	13	P	_	_

1	That	_	DT	_	_	2	NMOD	_	_
2	judgment	_	NN	_	_	7	SBJ	_	_
3	,	_	,	_	_	7	P	_	_
4	in	_	IN	_	_	7	ADV	_	_
5	turn	_	NN	_	_	4	PMOD	_	_
6	,	_	,	_	_	7	P	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	reversed	_	VBN	_	_	7	VC	_	_
9	by	_	IN	_	_	8	LGS	_	_
10	the	_	DT	_	_	13	NMOD	_	_
11	U.S.	_	NNP	_	_	13	NAME	_	_
12	Supreme	_	NNP	_	_	13	NAME	_	_
13	Court	_	NNP	_	_	9	PMOD	_	_
14	,	_	,	_	_	8	P	_	_
15	leaving	_	VBG	_	_	8	ADV	_	_
16	Cohen	_	NNP	_	_	15	OBJ	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	Boyer	_	NNP	_	_	17	CONJ	_	_
19	holding	_	VBG	_	_	15	OPRD	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	first	_	JJ	_	_	22	NMOD	_	_
22	patents	_	NNS	_	_	19	OBJ	_	_
23	for	_	IN	_	_	22	NMOD	_	_
24	making	_	VBG	_	_	23	PMOD	_	_
25	recombinant	_	JJ	_	_	26	NMOD	_	_
26	DNA	_	NNP	_	_	24	OBJ	_	_
27	(	_	(	_	_	22	PRN	_	_
28	now	_	RB	_	_	29	TMP	_	_
29	assigned	_	VBN	_	_	27	DEP	_	_
30	to	_	TO	_	_	29	ADV	_	_
31	their	_	PRP$	_	_	32	NMOD	_	_
32	schools	_	NNS	_	_	30	PMOD	_	_
33	)	_	)	_	_	27	P	_	_
34	.	_	.	_	_	7	P	_	_

1	Gene-splicing	_	NN	_	_	3	SBJ	_	_
2	now	_	RB	_	_	3	TMP	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	an	_	DT	_	_	6	NMOD	_	_
5	integral	_	JJ	_	_	6	NMOD	_	_
6	part	_	NN	_	_	3	PRD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	drug	_	NN	_	_	10	NMOD	_	_
10	business	_	NN	_	_	7	PMOD	_	_
11	.	_	.	_	_	3	P	_	_

1	Genentech	_	NN	_	_	4	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	1988	_	CD	_	_	4	NMOD	_	_
4	sales	_	NNS	_	_	5	SBJ	_	_
5	were	_	VBD	_	_	0	ROOT	_	_
6	$	_	$	_	_	5	PRD	_	_
7	335	_	CD	_	_	6	DEP	_	_
8	million	_	CD	_	_	6	DEP	_	_
9	,	_	,	_	_	5	P	_	_
10	both	_	CC	_	_	11	DEP	_	_
11	from	_	IN	_	_	5	ADV	_	_
12	licensing	_	NN	_	_	11	COORD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	its	_	PRP$	_	_	16	NMOD	_	_
15	own	_	JJ	_	_	16	NMOD	_	_
16	products	_	NNS	_	_	13	CONJ	_	_
17	.	_	.	_	_	5	P	_	_

